Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 8,407,843 | 7,851,912 | 6,876,588 | 6,158,682 | 5,379,751 |
| Cost of Goods | 3,684,727 | 3,505,273 | 3,139,972 | 2,910,092 | 2,556,655 |
| Gross Profit | 4,723,116 | 4,346,639 | 3,736,616 | 3,248,590 | 2,823,096 |
| Operating Expenses | 2,869,877 | 2,605,899 | 2,180,558 | 1,842,641 | 1,602,639 |
| Operating Income | 1,853,966 | 1,741,013 | 1,557,030 | 1,406,041 | 1,221,112 |
| Interest Expense | 54,283 | 52,961 | 63,831 | 91,425 | 74,393 |
| Other Income | 143,547 | 50,701 | 51,023 | 36,117 | 47,492 |
| Pre-tax Income | 1,943,230 | 1,738,753 | 1,544,222 | 1,350,733 | 1,194,211 |
| Income Tax | 544,104 | 499,696 | 455,545 | 384,959 | 334,379 |
| Net Income Continuous | 1,399,126 | 1,239,057 | 1,088,677 | 965,774 | 859,832 |
| Net Income Discontinuous | 0 | 0 | 68 | 0 | 0 |
| Net Income | $1,399,126 | $1,239,057 | $1,088,745 | $965,774 | $859,832 |
| EPS Basic Total Ops | 0.85 | 0.74 | 0.64 | 0.56 | 0.48 |
| EPS Basic Continuous Ops | 0.85 | 0.74 | 0.64 | 0.56 | 0.49 |
| EPS Diluted Total Ops | 0.85 | 0.74 | 0.64 | 0.56 | 0.49 |
| EPS Diluted Continuous Ops | 0.85 | 0.74 | 0.64 | 0.56 | 0.49 |
| EBITDA(a) | $2,338,047 | $2,168,795 | $1,936,047 | $1,761,927 | $1,528,443 |